Abstract

Purpose: To analyze varying clinical presentations, histopathological features, and management outcome of sebaceous gland carcinoma (SGC) of the eyelid. Materials and methods: We retrospectively reviewed medical records of 30 patients with histologically proven cases of SGC of eyelid treated at tertiary care hospital. Results: Patients were in the age group of 28-80 years, among which 18 (60%) were females and 12 (40%) were males. Mean follow-up period was 29.83 ± 8.14 months. Six out of 30 cases were lost to follow-up; hence, only 24 cases were analyzed for reconstruction techniques and management outcome. Initial anatomic sites involved were upper eyelid (10 cases [33.33%]), lower eyelid (5 cases [16.66%]), both upper and lower eyelid (10 cases [33.33%]), and medial canthus (1 case [3.33%]). Orbital extension at presentation was present in 4 cases (13.33%) while metastasis to preauricular lymph nodes was seen in 1 case (3.33%). T2 was the most common category according to TNM staging (14, 58.33%). Reconstruction techniques included direct closure with or without cantholysis in 5 (20.83%), closure with Tenzel's semicircular flap in 2 (8.33%), Cutler Beard repair in 5 (20.83%), and Hughes's flap with either cheek advancement flap or full-thickness skin graft in 3 (12.5%). Both upper eyelid and lower eyelid repair were done in three (12.5%) cases and medial canthal repair in one (4.16%) case. Five (20.83%) cases underwent exenteration. On histopathological examination, 23 (95.83%) patients had localized tumors while only 1 (4.16%) patient had pagetoid invasion. Recurrence was observed in three (12.5%) cases. One (4.16%) case died subsequent to brain metastasis. Conclusion: SGC of eyelid may have varied presentations, but early diagnosis and consequent surgical therapy has good outcome and higher survival rate.

Keywords

Publication details

DOI
10.4103/ojo.ojo_139_2017
Journal
Oman Journal of Ophthalmology, 11(1), 21-27
Publisher
Medknow Publications
Open access
Gold open access

Cite this article

APA 7

Rizvi, S. A. R., Alam, M. S., & Akhtar, K. (2018). Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome. Oman Journal of Ophthalmology, 11(1), 21-27. https://doi.org/10.4103/ojo.ojo_139_2017

MLA 9

Rizvi, Syed Ali Raza, et al. "Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome." Oman Journal of Ophthalmology, vol. 11, no. 1, 2018, pp. 21-27. https://doi.org/10.4103/ojo.ojo_139_2017.

Chicago (author–date)

Rizvi, Syed Ali Raza, Md Shahid Alam, and Kafil Akhtar. 2018. "Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome." Oman Journal of Ophthalmology 11 (1): 21-27. https://doi.org/10.4103/ojo.ojo_139_2017.

Harvard

Rizvi, S. A. R., Alam, M. S. and Akhtar, K. (2018) 'Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome', Oman Journal of Ophthalmology, 11(1), pp. 21-27. doi:10.4103/ojo.ojo_139_2017.

Vancouver

Rizvi SAR, Alam MS, Akhtar K. Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome. Oman Journal of Ophthalmology. 2018;11(1):21-27. doi:10.4103/ojo.ojo_139_2017

IEEE

S. A. R. Rizvi, M. S. Alam, and K. Akhtar, "Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome," Oman Journal of Ophthalmology, vol. 11, no. 1, pp. 21-27, 2018, doi: 10.4103/ojo.ojo_139_2017.